IPO Review

Veloxa Industries IPO Review: GMP, Financials & Valuation Analysis

Veloxa Industries is bringing a ₹1,240 crore mainboard issue with strong 15.7% GMP. Here is a breakdown of its financial growth, valuation vs peers, and key risks.

IPOSathi Research2 min read
Veloxa Industries IPO Review: GMP, Financials & Valuation Analysis

Veloxa Industries has opened its ₹1,240 crore mainboard initial public offering, making it one of the largest specialty chemical issues of the quarter.

With a price band of ₹412 to ₹434 per share and an active grey market premium hovering around ₹68 (15.7%), retail and institutional interest has built up rapidly. In this review, we examine the company's financial trajectory, valuation metrics compared to listed peers, and key operational risks.

Company Overview & Business Model

Founded in 2005 and operating out of Vadodara, Gujarat, Veloxa Industries manufactures specialty performance chemicals used in agrochemical, pharmaceutical, and high-performance coating formulations.

The company operates three manufacturing facilities in Gujarat, with a fourth unit currently under development in Dahej. Over 60% of its revenue is anchored by long-term customer contracts, serving over 140 domestic and global clients across 20 countries.

Financial Performance Track Record

Veloxa has demonstrated steady top-line and bottom-line growth over the past three fiscal years:

Fiscal YearRevenue (₹ Cr)Profit After Tax (₹ Cr)Total Assets (₹ Cr)PAT Margin
FY24₹980 Cr₹96 Cr₹1,840 Cr9.8%
FY25₹1,120 Cr₹128 Cr₹2,210 Cr11.4%
FY26₹1,340 Cr₹162 Cr₹2,640 Cr12.1%

Revenue has grown at a 19% CAGR, while profit after tax (PAT) margins expanded from 9.8% in FY24 to 12.1% in FY26 due to higher capacity utilization and backward integration of key chemical intermediates.

Valuation & Peer Comparison

At the upper price band of ₹434, the company commands a post-issue market capitalization of ₹4,120 crore.

Company NamePost-IPO P/EROE (%)Annual Revenue
Veloxa Industries24.1x18.6%₹1,340 Cr
Anupam Rasayan38.4x14.2%₹1,340 Cr
Navin Fluorine45.7x12.8%₹1,890 Cr
Vinati Organics41.2x19.4%₹2,010 Cr

At 24.1x post-issue P/E, Veloxa is priced at a reasonable discount to established peers like Anupam Rasayan (38.4x) and Vinati Organics (41.2x), providing a margin of safety for long-term investors.

Key Investment Strengths & Risks

Strengths

  • Diversified Client Base: Broad exposure across agrochemicals, pharma, and industrial coatings prevents dependency on any single industry.
  • Backward Integration: Internal production of core intermediates insulates margins from raw material price spikes.
  • Strong Financial Return Metrics: Healthy Return on Equity (ROE) of 18.6%.

Key Risks

  • Raw Material Volatility: Crude oil derivative prices directly impact production costs.
  • Geographic Concentration: Over 70% of production capacity is located in two GIDC facilities in Gujarat.

Summary Verdict

Veloxa Industries combines a solid 19% growth trajectory, expanding margins, and reasonable valuation relative to its peer group. While raw material fluctuations remain a watchpoint, the ₹68 (15.7%) grey market premium reflects positive institutional and retail sentiment.


Nothing here is investment advice. IPO investing carries risk, including the risk of listing below issue price. Consult a SEBI-registered adviser before making any investment decision.

Frequently asked questions

What is the issue size of Veloxa Industries IPO?+

Veloxa Industries IPO is a ₹1,240 crore mainboard issue comprising a fresh issue and an offer for sale.

What is the price band and lot size for Veloxa Industries IPO?+

The price band is ₹412 to ₹434 per equity share, with a minimum lot size of 34 shares (₹14,756 minimum investment).

What is the current GMP of Veloxa Industries IPO?+

As of today, Veloxa Industries IPO commands a GMP of ₹68 per share, indicating a potential ~15.7% listing gain.